- Home
- Publications
-
A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder.
This page provides detailed information about this publication. Please click on any text which is underlined to find more information.
- Authors
- Myriam Harfterkamp, Gigi van de Loo-Neus, Ruud B. Minderaa, Rutger Jan van der Gaag, Rodrigo Escobar, Alexander Schacht, Sireesha Pamulapati, Jan K. Buitelaar, Pieter J. Hoekstra
- Title
- A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder.
- Journal
- Journal of the American Academy of Child and Adolescent Psychiatry
- Year
- 2012
- Volume
- 5
- Issue
- 7
- Page(s)
- pp. 733-741.
- Abstract Link
- Read Abstract (New Window)
- Publication Format
- Journal Article
- Efficacy Study/Review
- Yes
- Scientific Validity
- Randomised Trial, Placebo, Peer-Reviewed, Double Blind, Controlled Trial, Comparative Study
- Comments
- Clinical Trial No. NCT00380692
- Keywords
- Adolescent / Secondary School Age, Atomoxetine, Attention Deficit Hyperactivity Disorder, Autism, Child/Children, Intervention, Medication, Primary / Elementary School Age, Selective Noradrenaline Re-Uptake Inhibitor
If you know of any other publications we should list on this page please email info@informationautism.org
Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.